European, Industry news, News 30/07/2025 To be (consistent) or not to be, that is the question in referral G1/25 On 29 July 2025, a Board of Appeal at the European Patent Office (EPO) in their interlocutory decision T0697/22 has referred several questions to the Enlarged Board of Appeal at the EPO to seek clarity on when it is necessary to amend the description of a European patent or patent application in line with the claimed subject matter. The referral is G1/25.
Industry news, News 29/07/2025 Insects as a Sustainable Protein Source: Innovations and Patents Discover how insect protein offers a sustainable and nutritious alternative to traditional protein sources. Explore innovations in insect farming, processing, and the crucial role of intellectual property in this rapidly growing industry, addressing global food demands and environmental concerns.
European, News 28/07/2025 T 1561/23 and the first application of G 1/24 – Consulting the description to interpret patent claims The Enlarged Board of Appeal of the European Patent Office (EPO) recently issued a landmark decision in G 1/24 addressing a fundamental question in European patent law: how should patent claims be interpreted when assessing patentability?
News, UPC 25/07/2025 Important Update: The UPC claims jurisdiction over patent infringement in the UK On 18 July 2025, the Unified Patent Court (UPC) affirmed for the first time that it has jurisdiction to consider infringement of a European patent validated in the United Kingdom (See here). For many businesses, this decision represents a notable marker in how the UPC might be used to warn off infringement of a European patent that is taking place in the UK.
Events, News, Team news 24/07/2025 Meet Secerna Partners Jason Boakes and Charlotte Watkins at LSX USA Congress Secerna Partners, Jason Boakes and Charlotte Watkins, will be attending the LSX USA Congress in Boston, USA, from September 16th-17th, 2025. The LSX USA Congress is a premier event in North America, bringing together leading CEOs from the Biotech, Medtech, and Pharmatech sectors.
News, Trade Marks 23/07/2025 General Court Annuls EUIPO Decision: Ferrari’s Testarossa Trademark Back on Track Following an eight-year legal dispute, Ferrari has successfully defended its Testarossa trade mark in the European Union. On the 2nd July 2025, the General Court of the EU overturned the EUIPO’s original ruling that had revoked Ferrari’s EU trade mark rights for Testarossa. The new ruling in favour of Ferrari holds significance for brands with legacy trade marks in the EU and has lasting implications for what constitutes ‘genuine’ use under EU law.
News, Team news 22/07/2025 Seas the Day: Innovation Behind the Gear - Watermaker As the Seas the Day rowing team continue on their 8,000-mile odyssey across the Pacific Ocean, the cutting-edge equipment they rely on plays a vital role in ensuring their safety, efficiency, and communication during this epic voyage. Many of the features that make this gear indispensable are, or were, protected by patents. In this article, we delve into several key pieces of equipment that the team will rely on during their expedition.
Industry news, News 21/07/2025 UKIPO Initiates Consultation on Standard Essential Patents to Enhance Innovation Framework The UK Intellectual Property Office (UKIPO) has commenced a significant public consultation concerning the framework governing Standard Essential Patents (SEPs). This initiative, which began on July 15, 2025, and is scheduled to conclude on October 7, 2025, seeks to gather diverse perspectives on potential adjustments to the SEP ecosystem, with the overarching aim of fostering a more conducive environment for innovation and economic growth within the United Kingdom.
Events, News, Trade Marks 21/07/2025 Lunch & Learn: The Ins and Outs of Trade Marks with Sam Turton Join us at Patch, York for 'Lunch & Learn: The Ins and Outs of Trade Marks' with Sam Turton on Thursday 31st July at 12:30pm. This is a fantastic opportunity to safeguard your intellectual property and ensure your brand's long-term success. We look forward to seeing you there.
